ANIZOME™, the first company to offer a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition, is launched today. The collection of microorganisms that inhabit the bodies of humans and animals have been studied extensively in recent years and play an important role in maintaining host health. While over $1 billion has been…
ANIZOME LLC was founded in 2018 as a result of a ground-breaking venture between Baylor College of Medicine, Stonehaven Incubate AG and Diversigen Inc. This unique combination of microbiome expertise, industry knowledge and commercial experience has enabled ANIZOME to establish a world-class animal microbiome platform that bridges the gap between research and commercial solutions.
Located in the Texas Medical Centre, the world’s largest health science complex, ANIZOME’s experienced team of experts are building on more than a decade of breakthrough discovery in the microbiome to develop next generation solutions for both farm and companion animals.